Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy

2022-03-23T12:05:49+00:00March 23rd, 2022|

Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy AML cancer cells CONTACT US Summary This study investigated the efficiency [...]

Autologous Dendritic Cells Combined with Cytokine-induced Killer Cells Synergize Low-dose Chemotherapy in Elderly Patients with Acute Myeloid Leuakemia

2022-02-08T10:30:39+00:00February 8th, 2022|

Autologous Dendritic Cells Combined with Cytokine-induced Killer Cells Synergize Low-dose Chemotherapy in Elderly Patients with Acute Myeloid Leukaemia Acute Myeloid Leukaemia CONTACT US Summary The goal of the study [...]

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

2022-02-03T12:12:04+00:00February 3rd, 2022|

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients Skin biopsy CONTACT US Summary In this study, autologous leukemic apoptotic corpse-pulsed [...]

Successful alternative treatment for relapsed adult Acute Lymphoblastic Leukemia with Dendritic Cells- Cytokine-Induced Killer Cells combined with a rituximab-based regimen

2022-01-26T13:14:05+00:00January 26th, 2022|

Successful alternative treatment for relapsed adult Acute Lymphoblastic Leukemia with Dendritic Cells- Cytokine-Induced Killer Cells combined with a rituximab-based regimen Change In Expression CONTACT US Summary This study investigates [...]

Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia

2021-12-05T08:10:09+00:00November 4th, 2021|

Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia Results CONTACT US Summary In the current study, [...]

A novel allogeneic off-the-shelf Dendritic Cell Vaccine for post- remission treatment of elderly patients with Acute Myeloid Leukemia

2021-12-05T08:11:10+00:00November 4th, 2021|

A novel allogeneic off-the-shelf Dendritic Cell Vaccine for post- remission treatment of elderly patients with Acute Myeloid Leukemia % of proliferation CONTACT US Summary The options [...]

Go to Top